Table I.
Pathological information of ESCC patients and NONO expression.
| NONO expression level | ||||
|---|---|---|---|---|
| Variables | Weak + moderate (%) | Strong (%) | No. | P-value |
| Age | ||||
| >60 | 15 | 4 (28.6) | 11 (39.3) | 0.734 |
| <60 | 27 | 10 (71.4) | 17 (60.7) | |
| Sex | ||||
| Male | 32 | 11 (78.6) | 21 (75.0) | 1.000 |
| Female | 10 | 3 (21.4) | 7 (25.0) | |
| Tumor depth | ||||
| T1-2 | 6 | 5 (35.7) | 1 (3.6) | 0.011a |
| T3-4 | 36 | 9 (64.3) | 27 (96.4) | |
| LN metastasis | ||||
| N0 | 36 | 11 (78.6) | 25 (89.3) | 0.652 |
| N1/N2/N3 | 6 | 3 (21.4) | 3 (10.7) | |
| Pathological differentiation | ||||
| Well | 7 | 2 (14.2) | 5 (17.9) | 0.651 |
| Moderate | 21 | 6 (42.9) | 15 (53.6) | |
| Poor | 14 | 6 (42.9) | 8 (28.5) | |
| AJCC stage | ||||
| I | 5 | 2 (14.3) | 3 (10.7) | 0.860 |
| II | 26 | 9 (64.3) | 17 (60.7) | |
| III–IV | 11 | 3 (21.4) | 8 (28.6) | |
AJCC, American Joint Commission on Cancer. ESCC, esophageal squamous cell carcinoma. The associations of pathological information of ESCC patients with NONO expression are summarized and statistically analyzed by Fisher's exact test.
a
P<0.05, significant difference.